30.3 C
New York
Sunday, June 23, 2024

Hims Just Launched an Ozempic Dupe

The $120 billion company has added a weight-loss drug to its mix of bargain healthcare treatments. San Francisco-based online healthcare platform Hims & Hers is disrupting a new healthcare category: The company just rolled out a bargain semaglutide medication that could compete with Ozempic. The Hims …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,047FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x